Fundraising FoxEurofarma Ventures
Corporate VCSeed–Growth
Find your way into Eurofarma Ventures
Sign up to see every warm intro you have to Eurofarma Ventures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Eurofarma Ventures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
What they invest in
from 1 of 2 portfolio companiesBiotech ×1Healthtech ×1
HQs:United States×1
Investments · 2 tracked
founders shown can be your intro pathBy year:2026 · 12023 · 12 dated
Abcuro develops therapies that target highly cytotoxic T cells for autoimmune diseases, including its lead candidate ulviprubart for inclusion body myositis.
BiotechHealthtechNewton, US
Steven A. Greenberg(Chief Scientific Advisor & Co-Founder)Steven A. Greenberg, MD(Chief Scientific Advisor & Co-Founder)John Alexander Martin(Executive Officer, Director)Stefano Gulla(Founder)Evan Thompson(Executive Officer)David de Graaf(Executive Officer, Director)
Co-investorsBain Capital Life SciencesNew Enterprise Associates (NEA)RA CapitalSamsara BioCapitalSanofi VenturesMass General Brigham Ventures+8 more
Boston-based biotech developing drugs against the 'dark genome'/repeatome for autoimmune disease, cancer and neurodegeneration.
Benjamin Greenbaum(Founder)David Ting(Founder)Rosana Kapeller(Founder)
Co-investorsAndreessen HorowitzARCH Venture PartnersGV (Google Ventures)Luma GroupSanofi VenturesAbingworth+11 more
Portfolio news
latest coverage across their companiesAbcuro · finsmes.com · Aug 18, 2026
Frequently asked questions
- What stage does Eurofarma Ventures invest at?
- Eurofarma Ventures invests at the Seed, Series A, Series B, Series C, Growth stages.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Capricorn Partners is an independent manager of venture capital funds and the listed investment company Quest for Growth, backing innovative companies that use technology as a competitive advantage.
Cathay Innovation is a multi-stage venture capital firm backed by industry, investing in startups building technologies that transform how people live and work. It operates a global platform for startup–corporate collaboration.
Collaborative Fund is a venture capital firm that backs entrepreneurs building category- and culture-defining brands, products, and services across consumer, health, energy, and access-to-capital themes.
Dot Capital is a New York City-based boutique venture capital firm founded in 2012 that invests in disruptive growth technology companies across sectors such as SaaS, mobile, internet infrastructure, big data, IoT, sharing economy and digital media.